Contributions of humoral and cellular immunity to vaccine-induced protection in humans

被引:184
作者
Amanna, Ian J. [2 ]
Slifka, Mark K. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Najit Technol Inc, Beaverton, OR 97006 USA
基金
美国国家卫生研究院;
关键词
Vaccines; Immunity; LIVED PLASMA-CELLS; MHC CLASS-II; CD8; T-CELLS; MEDIATED CYTOLYTIC ACTIVITY; VIRUS-SPECIFIC CD4+; LONG-TERM EFFICACY; MEMORY B-CELLS; CUTTING EDGE; BONE-MARROW; IN-VIVO;
D O I
10.1016/j.virol.2010.12.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccines play a vital role in protecting the host against infectious disease. The most effective licensed vaccines elicit long-term antigen-specific antibody responses by plasma cells in addition to the development of persisting T cell and B cell memory. The relative contributions of these different immune cell subsets are context-dependent and vary depending on the attributes of the vaccine (i.e., live/attenuated, inactivated, and subunit) as well as the biology of the pathogen in question. For relatively simple vaccines against bacterial antigens (e.g., tetanus toxin) or invariant viruses, the immunological correlates of protection are well-characterized. For more complex vaccines against viruses, especially those that mutate or cause latent infections, it is more difficult to define the specific correlates of immunity. This often requires observational/natural history studies, clinical trials, or experimental evaluation in relevant animal models in order for immunological correlates to be determined or extrapolated. In this review, we will discuss the relative contributions of virus-specific T cell and B cell responses to vaccine-mediated protection against disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 169 条
  • [1] Maintenance of the plasma cell pool is independent of memory B cells
    Ahuja, Anupama
    Anderson, Shannon M.
    Khalil, Ashraf
    Shlomchik, Mark J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (12) : 4802 - 4807
  • [2] Public fear of vaccination: Separating fact from fiction
    Amanna, I
    Slifka, MK
    [J]. VIRAL IMMUNOLOGY, 2005, 18 (02) : 307 - 315
  • [3] Duration of humoral immunity to common viral and vaccine antigens
    Amanna, Ian J.
    Carlson, Nichole E.
    Slifka, Mark K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) : 1903 - 1915
  • [4] Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
    Amanna, Ian J.
    Slifka, Mark K.
    [J]. IMMUNOLOGICAL REVIEWS, 2010, 236 : 125 - 138
  • [5] Wanted, dead or alive: New viral vaccines
    Amanna, Ian J.
    Slifka, Mark K.
    [J]. ANTIVIRAL RESEARCH, 2009, 84 (02) : 119 - 130
  • [6] AMANNA IJ, 2008, HUM VACCIN, V4
  • [7] [Anonymous], 2007, Wkly Epidemiol Rec, V82, P425
  • [8] [Anonymous], 1798, INQUIRY CAUSES EFFEC
  • [9] Characterization of CD4+ CTLs ex vivo
    Appay, V
    Zaunders, JJ
    Papagno, L
    Sutton, J
    Jaramillo, A
    Waters, A
    Easterbrook, P
    Grey, P
    Smith, D
    McMichael, AJ
    Cooper, DA
    Rowland-Jones, SL
    Kelleher, AD
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (11) : 5954 - 5958
  • [10] Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells
    Arnold, PY
    Davidian, DK
    Mannie, MD
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3198 - 3205